Optimizing the dose of hydroxyurea therapy for patients with β-thalassemia intermedia (Hb E-β-thalassemia): a single center study from eastern India. （打开新窗口）

Bohara VV, Ray S, Chakrabarti P, Ray SS, Nath UK, Chaudhuri U.

来源‎: Hemoglobin 2014;38(1):44-8.

检索‎: PubMed 24144212

DOI码‎: 10.3109/03630269.2013.845844

https://www.ncbi.nlm.nih.gov/pubmed/24144212 （打开新窗口）

Hydroxyurea in thalassemia intermedia--a promising therapy. （打开新窗口）

Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP.

来源‎: Ann Hematol 2005;84(7):441-6.

检索‎: PubMed 15838670

DOI码‎: 10.1007/s00277-005-1026-4

https://www.ncbi.nlm.nih.gov/pubmed/15838670 （打开新窗口）

Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study. （打开新窗口）

Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB.

来源‎: J Clin Pathol 2010;63(2):147-50.

检索‎: PubMed 20154037

DOI码‎: 10.1136/jcp.2009.070391

https://www.ncbi.nlm.nih.gov/pubmed/20154037 （打开新窗口）

Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia. （打开新窗口）

Karimi M, Borzouee M, Mehrabani A, Cohan N.

来源‎: Eur J Haematol 2009;82(3):213-8.

检索‎: PubMed 19077048

DOI码‎: 10.1111/j.1600-0609.2008.01192.x

https://www.ncbi.nlm.nih.gov/pubmed/19077048 （打开新窗口）

Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia. （打开新窗口）

Karimi M, Mohammadi F, Behmanesh F, Samani SM, Borzouee M, Amoozgar H, Haghpanah S.

来源‎: Eur J Haematol 2010;84(1):52-8.

检索‎: PubMed 19799627

DOI码‎: 10.1111/j.1600-0609.2009.01356.x

https://www.ncbi.nlm.nih.gov/pubmed/19799627 （打开新窗口）

Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece. （打开新窗口）

Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.

来源‎: Blood Cells Mol Dis 2000;26(5):453-66.

检索‎: PubMed 11112383

DOI码‎: 10.1006/bcmd.2000.0328

https://www.ncbi.nlm.nih.gov/pubmed/11112383 （打开新窗口）

Fetal globin stimulant therapies in the beta-hemoglobinopathies: principles and current potential. （打开新窗口）

Perrine SP.

来源‎: Pediatr Ann 2008;37(5):339-46.

检索‎: PubMed 18543545

https://www.ncbi.nlm.nih.gov/pubmed/18543545 （打开新窗口）

Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. （打开新窗口）

Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP.

来源‎: Ann N Y Acad Sci 2005;1054:250-6.

检索‎: PubMed 16339672

DOI码‎: 10.1196/annals.1345.031

https://www.ncbi.nlm.nih.gov/pubmed/16339672 （打开新窗口）

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. （打开新窗口）

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

来源‎: Acta Haematol 2004;111(4):189-95.

检索‎: PubMed 15153710

DOI码‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 （打开新窗口）

Efficacy of erythropoietin on dialysis in patients with beta thalassemia minor. （打开新窗口）

Di Iorio B, De Nicola L, Bellizzi V, Minutolo R, Zamboli P, Rubino R, Fuiano G, Conte G.

来源‎: Blood Purif 2004;22(5):453-60.

检索‎: PubMed 15359104

DOI码‎: 10.1159/000080729

https://www.ncbi.nlm.nih.gov/pubmed/15359104 （打开新窗口）

The role of recombinant human erythropoietin in the treatment of thalassemia. （打开新窗口）

Rachmilewitz EA, Aker M.

来源‎: Ann N Y Acad Sci 1998;850:129-38.

检索‎: PubMed 9668535

https://www.ncbi.nlm.nih.gov/pubmed/9668535 （打开新窗口）

Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes. （打开新窗口）

Singer ST, Vichinsky EP, Sweeters N, Rachmilewitz E.

来源‎: Br J Haematol 2011;154(2):281-4.

检索‎: PubMed 21496003

DOI码‎: 10.1111/j.1365-2141.2011.08617.x

https://www.ncbi.nlm.nih.gov/pubmed/21496003 （打开新窗口）

The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia. （打开新窗口）

Thein SL.

来源‎: Blood Rev 2012;26 Suppl 1:S35-9.

检索‎: PubMed 22631042

DOI码‎: 10.1016/S0268-960X(12)70011-5

https://www.ncbi.nlm.nih.gov/pubmed/22631042 （打开新窗口）